Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. AO Cheek, K Kow, J Chen, JA McLachlan Environmental health perspectives 107 (4), 273-278, 1999 | 537 | 1999 |
Veterinary surgery: small animal-E-BOOK: 2-volume set KM Tobias, SA Johnston Elsevier Health Sciences, 2013 | 451 | 2013 |
Citric acid fermentation CP Kubicek, M Röhr, HJ Rehm Critical Reviews in Biotechnology 3 (4), 331-373, 1985 | 369 | 1985 |
Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis AF Schmidt, M Nielen, OH Klungel, AW Hoes, A De Boer, ... Preventive veterinary medicine 112 (3-4), 414-422, 2013 | 70 | 2013 |
Nitrogen fixation: endocrine disrupters and flavonoid signalling JE Fox, M Starcevic, KY Kow, ME Burow, JA McLachlan Nature 413 (6852), 128-130, 2001 | 66 | 2001 |
The inhibition of estrogen receptor-mediated responses by chloro-s-triazine-derived compounds is dependent on estradiol concentration in yeast DQ Tran, KY Kow, JA McLachlan, SF Arnold Biochemical and Biophysical Research Communications 227 (1), 140-146, 1996 | 60 | 1996 |
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases … CE Fahey, RJ Milner, K Barabas, D Lurie, K Kow, S Parfitt, S Lyles, ... Journal of the American Veterinary Medical Association 239 (2), 209-215, 2011 | 43 | 2011 |
NCI comparative oncology program testing of non-camptothecin indenoisoquinoline topoisomerase I inhibitors in naturally occurring canine lymphoma JH Burton, C Mazcko, A LeBlanc, JM Covey, J Ji, RJ Kinders, ... Clinical Cancer Research 24 (23), 5830-5840, 2018 | 41 | 2018 |
Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study DH Thamm, B Rose, K Kow, M Humbert, CD Mansfield, A Moussy, ... The Veterinary Journal 191 (1), 131-134, 2012 | 40 | 2012 |
Association between computed tomographic characteristics and fractures following stereotactic radiosurgery in dogs with appendicular osteosarcoma L Kubicek, D Vanderhart, K Wirth, Q An, M Chang, J Farese, F Bova, ... Veterinary Radiology & Ultrasound 57 (3), 321-330, 2016 | 37 | 2016 |
Endocrine disrupters and flavonoid signalling JE Fox, M Starcevic, KY Kow, ME Burow, JA McLachlan Nature 413 (6852), 128-129, 2001 | 37 | 2001 |
In vitro effects of Yunnan Baiyao on canine hemangiosarcoma cell lines KA Wirth, K Kow, ME Salute, NJ Bacon, RJ Milner Veterinary and Comparative Oncology 14 (3), 281-294, 2016 | 36 | 2016 |
In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines SE Lyles, RJ Milner, K Kow, ME Salute Veterinary and Comparative Oncology 10 (3), 223-235, 2012 | 34 | 2012 |
Retrospective evaluation of whole body computed tomography for tumor staging in dogs with primary appendicular osteosarcoma JL Talbott, SE Boston, RJ Milner, A Lejeune, CHM Souza, K Kow, ... Veterinary surgery 46 (1), 75-80, 2017 | 32 | 2017 |
Impact of telomerase status on canine osteosarcoma patients K Kow, DH Thamm, J Terry, K Grunerud, SM Bailey, SJ Withrow, SE Lana Journal of veterinary internal medicine 22 (6), 1366-1372, 2008 | 26 | 2008 |
Regulation by interleukin-1β of formation of a line of delimiting astrocytes following prenatal trauma to the brain of the mouse JL Scripter, J Ko, K Kow, A Arimura, CF Ide Experimental neurology 145 (2), 329-341, 1997 | 26 | 1997 |
Veterinary surgery: small animal expert consult-E-book SA Johnston, KM Tobias Elsevier Health Sciences, 2017 | 20 | 2017 |
Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis AF Schmidt, RHH Groenwold, P Amsellem, N Bacon, OH Klungel, ... Preventive Veterinary Medicine 125, 116-125, 2016 | 20 | 2016 |
Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells CE Fahey, RJ Milner, K Kow, NJ Bacon, ME Salute Anti-Cancer Drugs 24 (5), 519-526, 2013 | 19 | 2013 |
Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia ML Pérez, S Culver, JL Owen, M Dunbar, K Kow, M Breen, RJ Milner Anti-Cancer Drugs 24 (10), 1098-1103, 2013 | 17 | 2013 |